Treatment of pregnant and early postpartum women with severe and critical COVID-19: experience at a tertiary center

European Journal of Medical Research

Research

Frederico José Amedee Peret¹  Bárbara Braga Costa¹  Maria Aparecida Braga¹  Rodrigo Nacif Barbosa² 

[1] Unidade de Tratamento Intensivo, Maternidade Unimed-Unidade Grajaú, Belo Horizonte, Brazil;Unidade de Tratamento Intensivo, Maternidade Unimed-Unidade Grajaú, Belo Horizonte, Brazil;Rua Viamão, 1171, UTI adulto. Bairro Grajaú, CEP 30431-253, Belo Horizonte, Minas Gerais, Brazil;

关键词: Pregnancy;    COVID-19;    SARS-CoV-2;    Acute respiratory failure;    Mechanical ventilation;    Prone positioning;    Delivery;   

DOI  :  10.1186/s40001-022-00907-5

 received in 2022-10-08, accepted in 2022-11-20,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundThe management of acute respiratory failure during pregnancy is a poorly defined issue in the literature, especially regarding the use of the prone position and the appropriate time for delivery. This study describes our experience in treating pregnant and postpartum women with severe or critical coronavirus disease 2019 (COVID-19).Materials and methodsThis descriptive retrospective study included 25 pregnant and 4 postpartum women admitted to an ICU due to respiratory complications from COVID-19 from June 2020 to August 2021.ResultsThe mean maternal age was 33.6 years, and the median gestational age (GA) at admission was 33 weeks. Obesity was the most common comorbidity. The median time between symptom onset and ICU admission was 10 days, while the median length of ICU stay was 14 days. Invasive mechanical ventilation (IMV) was required in 16 (55.2%) patients for a median time of 16.5 days. Prone positioning (PP) was performed in 68.7% of the patients on IMV, and resulted in an expressive increase in arterial oxygen partial pressure to fractional inspired oxygen (PaO2/FiO2 ratio). Eleven (44%) pregnant women delivered during their ICU stay for obstetric or fetal reasons: of these, 2 (18%) developed postpartum hemorrhagic shock and 1 (9%) developed abdominal wall infection. None of the 25 pregnant women underwent delivery due to acute respiratory failure or in an attempt to avoid intubation. There were 2 fetal deaths, but no maternal or neonatal deaths.ConclusionWe observed favorable outcomes in pregnant and postpartum women with severe and critical COVID-19 admitted to our institution. This finding reinforces the effectiveness of PP in the treatment of hypoxemic respiratory failure secondary to COVID-19 in pregnant women undergoing IMV, and suggests that gestation should only be interrupted in cases of obstetric and fetal complications, provided the patient is stable, or when hypoxemia is refractory to PP.

【 授权许可】

CC BY   
© The Author(s) 2022